Synonym: (S)-(+)-Clopidogrel bisulfate; (S)-(+)-Methyl 2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate hydrogensulfate; Clopidogrel Bisulphate
CAS Number: 120202-66-6
Empirical Formula (Hill Notation): C16H16ClNO2S · H2SO4
Molecular Weight: 419.90
MDL Number: MFCD00876395
Linear Formula: C16H16ClNO2S · H2SO4
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML0004-10MG.
| assay |
≥98% (HPLC) |
| color |
white to tan |
| form |
powder |
| InChI |
1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1 |
| InChI key |
FDEODCTUSIWGLK-RSAXXLAASA-N |
| optical activity |
[α]/D +54 to +70°, c = 0.5 in methanol |
| originator |
Bristol-Myers Squibb |
| |
Sanofi Aventis |
| Quality Level |
100  |
| SMILES string |
OS(O)(=O)=O.COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl |
| solubility |
DMSO: ≥20 mg/mL (warmed) |
| storage temp. |
2-8°C |
| Application: |
(S)-(+)-Clopidogrel hydrogensulfate was used as standard in HPLC-MS/MS to detect clopidogrel and its thiol derivative in human plasma. |
| Biochem/physiol Actions: |
(S)-(+)-Clopidogrel hydrogen sulfate is an antithrombotic antiplatelet agent. |
| Biochem/physiol Actions: |
(S)-(+)-Clopidogrel hydrogen sulfate is an antithrombotic antiplatelet agent. It specifically and irreversibly inhibits the Purinoceptor P2Y12 subtype which inhibits ADP-induced platelet aggregation. (S)-(+)-Clopidogrel hydrogen sulfate is the active isomer. |
| Features and Benefits: |
This compound is featured on the P2 Receptors: P2Y G-Protein Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: |
This compound was developed by Bristol-Myers Squibb and Sanofi Aventis . To browse the list of other pharma-developed compounds, Approved Drugs, and Drug Candidates, click here . |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |